Moreover, the molecular pathways of chronic inflammation, which lead to insulin resistance, a decrease in insulin receptor levels, and apoptosis induction in pancreatic cells, must also be targeted to develop innovative therapeutic approaches for T2DM treatment. Here, INSR is linked to type 2 diabetes mellitus.